Literature DB >> 20035594

Psychotropic drug use among Icelandic children: a nationwide population-based study.

Helga Zoëga1, Gísli Baldursson, Birgir Hrafnkelsson, Anna Birna Almarsdóttir, Unnur Valdimarsdóttir, Matthías Halldórsson.   

Abstract

OBJECTIVE: The aim of this study was to investigate psychotropic drug use among children in Iceland between 2003 and 2007.
METHODS: A nationwide population-based drug use study covering the total pediatric population (ages 0-17) in Iceland. Information was obtained from the National Medicines Registry to calculate prevalence of use by year and psychotropic drug group; incidence by year, psychotropic drug group, child's age and sex, and medical specialty of prescriber; the most commonly used psychotropic chemical substances, off-label and unlicensed use and concomitant psychotropic drug use.
RESULTS: The overall prevalence of psychotropic drug use was 48.7 per 1000 Icelandic children in 2007. Stimulants and antidepressants increased in prevalence from 2003 to 2007 and were the two most prevalent psychotropic drug groups, respectively, 28.4 and 23.4 per 1000 children in 2007. A statistically significant trend of declining prevalence (p = 0.00013) and incidence (p = 0.0018) of antidepressant use occurred during the study period. Out of 21,986 psychotropic drugs dispensed in 2007, 25.4% were used off-label.
CONCLUSIONS: With reference to reports from other European countries, the results indicate extensive psychotropic drug use among children in Iceland between 2003 and 2007. Further scrutiny is needed to assess the rationale behind this widespread use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035594     DOI: 10.1089/cap.2009.0003

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  28 in total

1.  Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013.

Authors:  Hélène Verdoux; Elodie Pambrun; Sébastien Cortaredona; Marie Tournier; Pierre Verger
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01-07       Impact factor: 4.785

2.  Determination of psychotropic use in children and adolescents from a prescription database: methodological issues.

Authors:  Christian J Bachmann; Falk Hoffmann
Journal:  Psychopharmacology (Berl)       Date:  2014-08-15       Impact factor: 4.530

3.  Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

Authors:  Christian J Bachmann; Thomas Lempp; Gerd Glaeske; Falk Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2014-01-17       Impact factor: 5.594

4.  Effectiveness of mandatory peer review to reduce antipsychotic prescriptions for Medicaid-insured children.

Authors:  Ayse Akincigil; Thomas I Mackie; Sharon Cook; Robert J Hilt; Stephen Crystal
Journal:  Health Serv Res       Date:  2020-06-21       Impact factor: 3.402

5.  Age, academic performance, and stimulant prescribing for ADHD: a nationwide cohort study.

Authors:  Helga Zoëga; Unnur A Valdimarsdóttir; Sonia Hernández-Díaz
Journal:  Pediatrics       Date:  2012-11-19       Impact factor: 7.124

Review 6.  Recent international trends in psychotropic medication prescriptions for children and adolescents.

Authors:  Hans-Christoph Steinhausen
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-11-08       Impact factor: 4.785

7.  Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.

Authors:  Carsten Schröder; Michael Dörks; Bianca Kollhorst; Tilo Blenk; Ralf W Dittmann; Edeltraut Garbe; Oliver Riedel
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-13       Impact factor: 4.785

8.  National Patterns of Commonly Prescribed Psychotropic Medications to Young People.

Authors:  Ryan S Sultan; Christoph U Correll; Michael Schoenbaum; Marrisa King; John T Walkup; Mark Olfson
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-01-29       Impact factor: 2.576

9.  Use of SSRIs among Danish children: a nationwide study.

Authors:  Anton Pottegård; Helga Zoëga; Jesper Hallas; Per Damkier
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-02-04       Impact factor: 4.785

Review 10.  Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs.

Authors:  Jon Jureidini; Anne Tonkin; Elsa Jureidini
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.